Drug Sequencing

Drug sequencing is a pharmacotherapeutic strategy that belongs to the class of treatment planning methods in oncology, specifically distinguished by the systematic ordering of pharmacological agents over time to optimize therapeutic efficacy, minimize resistance, and reduce toxicity in the management of genitourinary cancers.

48

Publications

2.5K

Citations

588

Authors

200

Institutions

Publications per year

2017–2026

19

Publications

48

1–5 of 48

Authors

588

  1. ID
    Ian D. Schnadig

    Compass Oncology, United States

    2 publications · 61 citations

    2

    h-index

  2. MB
    Menaka Bhor

    Novartis (United States), United States

    2 publications · 61 citations

    2

    h-index

  3. RN
    Rosa Nadal

    Sidney Kimmel Comprehensive Cancer Center, United States

    2 publications · 81 citations

    2

    h-index

  4. LN
    Leonardo Nicacio

    Seagen (United States), United States

    2 publications · 61 citations

    2

    h-index

  5. ES
    Emmanuel S. Antonarakis

    Johns Hopkins University, United States

    2 publications · 81 citations

    2

    h-index

1–5 of 588

Venues

  1. PubMed

    Repository · 5 publications · 135 citations

    5

    h-index

  2. Journal of Clinical Oncology

    4 publications · 216 citations

    4

    h-index

  3. The Pharmacogenomics Journal

    3 publications · 73 citations

    3

    h-index

  4. The Lancet Oncology

    2 publications · 471 citations

    2

    h-index

  5. The Oncologist

    2 publications · 34 citations

    2

    h-index

1–5